SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-091874
Filing Date
2024-08-06
Accepted
2024-08-06 16:25:29
Documents
15
Period of Report
2024-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-20240731.htm   iXBRL 8-K 58985
2 EX-10.1 tlis-ex10_1.htm EX-10.1 45711
3 EX-10.2 tlis-ex10_2.htm EX-10.2 45806
4 EX-10.3 tlis-ex10_3.htm EX-10.3 118106
5 EX-10.4 tlis-ex10_4.htm EX-10.4 115721
  Complete submission text file 0000950170-24-091874.txt   589876

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tlis-20240731.xsd EX-101.SCH 47767
17 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20240731_htm.xml XML 4895
Mailing Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607
Business Address 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 241179724
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)